Dose and safety concerns of clozapine: Worldwide package inserts need revisions

Jose de Leon, Can Jun Ruan, Georgios Schoretsanitis, John M. Kane

Research output: Contribution to journalComment/debate

25 Scopus citations
Original languageEnglish
Pages (from-to)2-4
Number of pages3
JournalSchizophrenia Research
Volume216
DOIs
StatePublished - Feb 2020

Bibliographical note

Funding Information:
The authors acknowledge Lorraine Maw, M.A., at the Mental Health Research Center at Eastern State Hospital, Lexington, Kentucky, who helped in editing this article. Dr. Ruan is supported by a 2019 NARSAD Young Investigator Award. The authors are grateful to the reviewers who provided important suggestions for improving the article.

Funding Information:
The authors acknowledge Lorraine Maw, M.A. at the Mental Health Research Center at Eastern State Hospital, Lexington, Kentucky, who helped in editing this article. Dr. Ruan is supported by a 2019 NARSAD Young Investigator Award. The authors are grateful to the reviewers who provided important suggestions for improving the article.

Keywords

  • Clozapine/metabolism
  • Clozapine/pharmacokinetics
  • Drug interaction
  • Drug labeling
  • Infection
  • Inflammation
  • Myocarditis
  • Pneumonia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Fingerprint

Dive into the research topics of 'Dose and safety concerns of clozapine: Worldwide package inserts need revisions'. Together they form a unique fingerprint.

Cite this